XML 21 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Shareholder Report
 12 Months Ended
Apr. 30, 2025
USD ($)
$ / shares
Shareholder Report [Line Items]  
Document Type N-CSR
Amendment Flag false
Registrant Name Putnam ETF Trust
Entity Central Index Key 0001845809
Entity Investment Company Type N-1A
Document Period End Date Apr. 30, 2025
Putnam PanAgora ESG Emerging Markets Equity ETF  
Shareholder Report [Line Items]  
Fund Name Putnam PanAgora ESG Emerging Markets Equity ETF
Class Name Putnam PanAgora ESG Emerging Markets Equity ETF
Trading Symbol PPEM
Security Exchange Name NYSEArca
Annual or Semi-Annual Statement [Text Block] This annual shareholder report contains important information about Putnam PanAgora ESG Emerging Markets Equity ETF for the period May 1, 2024, to April 30, 2025.
Shareholder Report Annual or Semi-Annual annual shareholder report
Additional Information [Text Block] You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
Material Fund Change Notice [Text Block]
This report describes changes to the Fund that occurred during the reporting period.
Additional Information Phone Number (800) DIAL BEN/342-5236
Additional Information Website https://www.franklintempleton.com/regulatory-fund-documents
Expenses [Text Block]
WHAT WERE THE FUND COSTS FOR THE LAST YEAR? (based on a hypothetical $10,000 investment)
Fund Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment*
Putnam PanAgora ESG Emerging Markets Equity ETF
$63
0.60%
[1]
Expenses Paid, Amount $ 63
Expense Ratio, Percent 0.60%
Factors Affecting Performance [Text Block]
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2025, Putnam PanAgora ESG Emerging Markets Equity ETF returned 10.08%. The Fund compares its performance to the MSCI Emerging Markets Index-NR, which returned 9.02% for the same period.  
PERFORMANCE HIGHLIGHTS
Top contributors to performance:
↑
Market intelligence and ESG factor composites, as all factors outperformed.
↑
Among countries, Taiwan was the top contributor. Within the country, an overweight position in Taiwan Semiconductor Manufacturing, a contract chipmaker, was one of the top performers. It was held overweight due to its high scores in short sell and momentum factors. The company’s stock surged, driven by soaring demand for artificial intelligence (AI) chips, which resulted in record revenues and strong growth in AI-related hardware sales, which exceeded earnings expectations.
↑
Among sectors, materials was the top contributor. An overweight position in Gold Fields, a South African gold miner, was the top performer within the sector. The company saw its stock rise due to surging gold prices. The company’s profits jumped, supported by strong market demand and production at its new Chilean mine. The company was held overweight due to its high scores in prediction and quality factors.
Top detractors from performance:
↓
Management & governance factor composite detracted from performance.
↓
Among countries, South Korea was the top detractor. An overweight position in Kia was the top detractor as the automaker saw its stock fall, driven by lagged earnings and U.S. tariffs on imported cars, hurting investor confidence and raising concerns about profitability and competitiveness. The company was held overweight due to its high factor scores in value and short sell (not held at period-end).
↓
Among sectors, health care was the top detractor. An overweight in Dr Reddy’s Laboratories, an Indian pharmaceutical company, was the top laggard in the sector. The decline of the stock was due to weak earnings, lower-than-expected margins, slow growth in India, and limited new product momentum in the U.S. amid tough generic drug competition. The company was held overweight due to its high scores in value, ESG score, and prediction factors. The Fund existed the position during reporting period.
Performance Past Does Not Indicate Future [Text] The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future.
Line Graph [Table Text Block]
image
Average Annual Return [Table Text Block]
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2025
 
1 Year
Since Inception
(1/19/2023)
Putnam PanAgora ESG Emerging Markets Equity ETF (NAV)
10.08
6.35
MSCI All Country World ex-U.S. Index-NR
11.93
10.15
MSCI Emerging Markets Index-NR
9.02
6.13
No Deduction of Taxes [Text Block] The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
Material Change Date May 01, 2024
Updated Performance Information Location [Text Block]
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit https://www.franklintempleton.com/investments/options/exchange-traded-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
Net Assets $ 43,168,912
Holdings Count | $ / shares 113 [2]
Advisory Fees Paid, Amount $ 201,714
Investment Company Portfolio Turnover 90.00%
Additional Fund Statistics [Text Block]
KEY FUND STATISTICS (as of April 30, 2025)
Total Net Assets
$43,168,912
Total Number of Portfolio Holdings*
113
Total Management Fee Paid (based on a unitary fee)
$201,714
Portfolio Turnover Rate
90%
[2]
Holdings [Text Block]
image
 [3]
Material Fund Change [Text Block]
HOW HAS THE FUND CHANGED?
On May 31, 2023, Franklin Resources, Inc. (“Franklin Templeton”) and Great-West Lifeco Inc., the parent company of Putnam U.S. Holdings I, LLC (“Putnam Holdings”), announced that they had entered into a definitive agreement for a subsidiary of Franklin Templeton to acquire Putnam Holdings in a stock and cash transaction (the “Transaction”). The Transaction was completed on January 1, 2024. As part of the Transaction, your Fund’s investment advisor, Putnam Investment Management, LLC (“Putnam Management”), a wholly-owned subsidiary of Putnam Holdings, became an indirect, wholly-owned subsidiary of Franklin Templeton. In connection with the Transaction, shareholders of your Fund approved a new management contract with Putnam Management and a new sub-advisory contract with PanAgora Asset Management, Inc., your Fund’s sub-advisor. The new contracts were identical to the previous contracts, except for the effective dates, initial terms, updates to fund names as necessary to reflect previous name changes, and certain non-substantive changes.
This is a summary of certain changes to the Fund since May 1, 2024. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2025,
at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or       
funddocuments@putnam.com.
Updated Prospectus Phone Number (800) DIAL BEN/342-5236
Updated Prospectus Email Address funddocuments@putnam.com
Updated Prospectus Web Address https://www.franklintempleton.com/regulatory-fund-documents
[1]
* Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.
[2]
* Includes derivatives, if applicable.
[3]
Cash and Equivalents, if any, represent the market value weights of cash, derivatives, short-term securities, and other unclassified assets in the portfolio. Holdings and allocations may vary over time.